Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Post by jawcellison Jun 24, 2015 11:04am
217 Views
Post# 23863391

June 24

June 24
Laser therapy

is about to get a

whole lot smarter

Theralase's TLC-2000 therapeutic laser system will be available in Canada soon. The intelligent laser system provides customized, patient-centric healing. Our patented Cell Sensing technology collects feedback from the patient's tissue and adjusts the dosage to meet their individual needs.

Click below for a third and final sneak-preview of the TLC-2000.

TLC-2000
Learn More
Click to sign up for more details
about the TLC-2000 Laser System


Theralase Technologies Inc. is listed on the TSX Venture (TSXV: TLT) (TLTFF: OTC Pink®).

Additional information is available at www.theralase.com and www.sedar.com.


Theralase Technologies Inc. was recognized as a TSX Venture 50® company in 2015.

TSX Venture 50 is a trademark of TSX Inc. and is used under license.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities